| Literature DB >> 21742576 |
Faruque Parvez1, Gail A Wasserman, Pam Factor-Litvak, Xinhua Liu, Vesna Slavkovich, Abu B Siddique, Rebeka Sultana, Ruksana Sultana, Tariqul Islam, Diane Levy, Jacob L Mey, Alexander van Geen, Khalid Khan, Jennie Kline, Habibul Ahsan, Joseph H Graziano.
Abstract
BACKGROUND: Several reports indicate that drinking water arsenic (WAs) and manganese (WMn) are associated with children's intellectual function. Very little is known, however, about possible associations with other neurologic outcomes such as motor function.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21742576 PMCID: PMC3226503 DOI: 10.1289/ehp.1103548
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Study participant characteristics and exposure measures by WAs and WMn distribution.
| WAs and WMn levels | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristics and exposure measures | Overall ( | Low As–low Mn ( | Low As–high Mn ( | High As–low Mn ( | High As–high Mn ( | |||||||
| Participants’ characteristics | ||||||||||||
| Male [ | 50.0 (151) | 61.0 (47) | 48.6 (36) | 43.8 (32) | 45.5 (36) | 0.13 | ||||||
| Child age (years) | 9.6 ± 0.7 | 9.5 ± 0.8 | 9.6 ± 0.73 | 9.8 ± 0.7 | 9.5 ± 0.8 | 0.14 | ||||||
| Month attending school | 42.0 ± 16.2 | 43.3 ± 18.52 | 42.4 ± 14.8 | 42.5 ± 14.0 | 39.8 ± 17.1 | 0.69 | ||||||
| Grade | 2.9 ± 1.2 | 3.0 ± 1.3 | 2.8 ± 1.2 | 3.0 ± 1.1 | 2.9 ± 1.2 | 0.37 | ||||||
| Head circumference (cm) | 49.3 ± 1.4 | 49.3 ± 1.2 | 49.3 ± 1.4 | 49.0 ± 1.3 | 49.7 ± 1.7 | 0.17 | ||||||
| Mother’s WASI raw score | 31.0 ± 10.6 | 32.0 ± 9.7 | 30.2 ± 10.6 | 31.5 ± 10.8 | 30.2 ± 11.2 | 0.41 | ||||||
| Exposure measures | ||||||||||||
| Blood (μg/L) | ||||||||||||
| BAs | 4.8 ± 3.2 | 3.2 ± 1.7 | 3.4 ± 1.7 | 6.2 ± 4.2 | 6.3 ± 3.0 | < 0.0001 | ||||||
| BMn | 14.7 ± 3.7 | 14.5 ± 3.8 | 15.4 ± 4.1 | 14.3 ± 3.5 | 14.6 ± 3.2 | 0.49 | ||||||
| BSe | 104.9 ± 17.2 | 106.4 ± 16.2 | 103.6 ± 15.5 | 106.7 ± 18.0 | 103.0 ± 18.7 | 0.43 | ||||||
| BPb | 114.5 ± 37.2 | 123.9 ± 38.4 | 113.9 ± 42.4 | 100.9 ± 30.5 | 118.5 ± 33.1 | 0.0009 | ||||||
| Water (μg/L) | ||||||||||||
| WAs | 43.3 ± 73.6 | 2.3 ± 2.3 | 3.3 ± 2.7 | 97.3 ± 108.8 | 70.7 ± 58.1 | < 0.0001 | ||||||
| WMn | 725.5 ± 730.5 | 202.1 ± 145.4 | 1111.1 ± 686.1 | 184.0 ± 146.1 | 1367.1 ± 692.6 | < 0.0001 | ||||||
| Urine | ||||||||||||
| UAs (μg/L) | 78.0 ± 72.1 | 46.7 ± 35.8 | 52.3 ± 38.7 | 106.0 ± 93.0 | 107.0 ± 79.6 | < 0.0001 | ||||||
| UCr (mg/dL) | 35.0 ± 24.1 | 35.0 ± 25.0 | 33.7 ± 24.4 | 36.8 ± 24.9 | 34.4 ± 22.6 | 0.97 | ||||||
| UAs (μg/g creatinine) | 246.5 ± 183.9 | 149.5 ± 74.4 | 173.3 ± 111.7 | 330.5 ± 247.4 | 332.0 ± 170.4 | < 0.0001 | ||||||
| NAs (μg/g) | 5.9 ± 6.3 | 2.9 ± 2.5 | 3.0 ± 2.2 | 6.9 ± 7.0 | 10.6 ± 7.7 | < 0.0001 | ||||||
| Hemoglobin (g/dL) | 12.4 ± 0.9 | 12.7 ± 1.1 | 12.2 ± 0.8 | 12.3 ± 1.0 | 12.4 ± 0.8 | 0.002 | ||||||
| Plasma ferritin (ng/mL) | 33.4 ± 17.8 | 31.5 ± 16.8 | 32.1 ± 17.5 | 36.9 ± 18.1 | 33.1 ± 18.8 | 0.19 | ||||||
| Data are mean ± SD, except as noted. | ||||||||||||
BOT-2 scores (mean ± SD) by WAs and WMn category.
| Motor function measure | WAs and WMn levels | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall ( | Low As–low Mn ( | Low As–high Mn ( | High As–low Mn ( | High As–high Mn ( | ||||||||
| FMC | 42.3 ± 8.6 | 43.7 ± 7.6 | 42.8 ± 9.6 | 41.7 ± 8.8 | 41.2 ± 8.2 | 0.26 | ||||||
| MC | 38.9 ± 7.3 | 39.7 ± 6.9 | 39.2 ± 7.8 | 38.4 ± 8.2 | 38.2 ± 6.4 | 0.56 | ||||||
| BC | 41.3 ± 6.0 | 42.7 ± 5.9 | 41.2 ± 6.0 | 41.2 ± 6.5 | 40.0 ± 5.7 | 0.07 | ||||||
| SA | 37.4 ± 3.7 | 37.7 ± 3.7 | 37.5 ± 3.5 | 37.3 ± 3.9 | 37.2 ± 3.8 | 0.81 | ||||||
| TMC | 160.0 ± 18.5 | 162.5 ± 17.3 | 161.2 ± 19.8 | 159.2 ± 19.8 | 157.2 ± 17.2 | 0.33 | ||||||
Estimated regression coefficients relating BAs to BOT-2 scores in models with and without adjustment for other variables [β (95% CI); n = 299].
| Exposure measure | FMC | MC | BC | SA | TMC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Before adjustment | ||||||||||
| As | –1.94 (–3.55, –0.35)** | –0.70 (–2.07, 0.66) | –1.38 (–2.50, –0.26)** | 0.07 (–0.63, 0.78) | –3.96 (–7.38, –0.55)* | |||||
| Mn | –2.93 (–7.02, 1.16) | –3.61 (–7.07, –0.16)* | –0.39 (–3.27, 2.47) | –1.37 (–3.16, 0.41) | –8.32 (–17.02, 0.39)# | |||||
| Se | 1.55 (0.40, 2.70)** | 1.57 (0.60, 2.55)** | 0.15 (–0.66, 0.97) | 0.26 (–0.25, 0.77) | 3.54 (1.10, 6.00)** | |||||
| After adjustment | ||||||||||
| As | –1.68 (–3.19, –0.18)* | –0.49 (–1.73, 0.76) | –1.61 (–2.70, –0.51)** | 0.15 (–0.57, 0.86) | –3.63 (–6.72, –0.54)* | |||||
| Mn | 1.62 (–2.53, 5.77) | 1.03 (–2.40, 4.47) | 2.03 (–0.99, 5.06) | –0.66 (–2.64, 1.31) | 4.02 (–4.52, 12.56) | |||||
| Se | 0.79 (–0.41, 1.98) | 1.02 (0.04, 1.99)* | 0.30 (–0.58, 1.66) | 0.09 (–0.48, 0.66) | 2.17 (–0.30, 4.63)† | |||||
Estimated regression coefficients relating measures of As exposure to BOT-2 scores [β (95% CI); n = 299)].
| Exposure measure | FMC | MC | BC | SA | TMC | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| WAs (μ/L) | –0.54 (–1.03, –0.05)* | –0.15 (–0.52, 0.30) | –0.43 (–0.77, –0.06)* | –0.11 (–0.28, 0.18) | –1.18 (–2.13, –0.10)* | |||||
| UAs (μ/L) | –1.03 (–2.45, 0.39) | –0.73 (–1.89, 0.44) | –1.43 (–2.67, –0.61)* | –0.19 (–0.86, 0.48) | –3.59 (–6.50, –0.68)** | |||||
| UAs (g creatinine/L) | –0.88 (–2.28, 0.51) | –0.76 (–1.91, 0.38) | –1.60 (–2.61, –0.60)** | –0.16 (–0.83, 0.49) | –3.42 (–6.27, –0.57)* | |||||
| NAs (μg/g) | –0.84 (–2.20, 0.50) | –0.68 (–1.80, 0.42) | –1.86 (–2.83, –0.89)** | –0.38 (–1.02, 0.25) | –3.77 (–6.52, –1.03)** | |||||
| The models are adjusted for sex, school attendance, head circumference, mother’s intelligence (WASI), BPb, BSe, Bas, and BMn measures. Exposure values are log transformed. * | ||||||||||
Figure 1Covariate-adjusted mean scores by BAs quartiles for FMC, BC, and TMC scores. Models were adjusted for school attendance, head circumference, mother’s intelligence (WASI), plasma ferritin, BPb, BSe, and BMn. Significance levels: FMC (p = 0.07), BC (p < 0.05) and TMC (p = 0.1). Difference scales were used for adjusted mean scores for TMC.